Although other inflammatory biomarkers like high-sensitivity C-reactive protein (hs-CRP) and leukocytes have been reported to be useful in predicting clinical outcome after stroke [31, 32], there has been no head-to-head study to date that compares these markers in terms of predictive value. The gene discussed is CRP; the disease is Stroke.